New ³Ô¹Ï±¬ÁÏ Vault QMS Brings Next Generation Quality Management to Life Sciences
Industry¡¯s first unified cloud solution breaks down silos in quality management, connects end-to-end processes across all global stakeholders
PLEASANTON, CA ¨C May 26, 2016 ¨C ³Ô¹Ï±¬ÁÏ Systems (NYSE:VEEV) today unveiled the industry¡¯s first cloud application that unifies quality management processes in life sciences. ³Ô¹Ï±¬ÁÏ Vault QMS replaces disparate, on-premise systems to manage global quality processes across an organization, including external partners. Together with ³Ô¹Ï±¬ÁÏ Vault QualityDocs, ³Ô¹Ï±¬ÁÏ now offers the only integrated suite of quality applications for seamless end-to-end content and quality management, delivering greater visibility and collaboration.
¡°Quality management solutions are crucial to ensuring product safety and ongoing regulatory compliance,¡± said Robert Lorence, vice president, Quality and Compliance Services at HighPoint Solutions. ¡°³Ô¹Ï±¬ÁÏ's new QMS application offers the market a powerful, modern, cloud alternative to existing on-premise quality management systems. In an industry segment continually looking for greater efficiency and effectiveness, this is welcome news.¡±
Increased global outsourcing of quality manufacturing, combined with intensified regulatory scrutiny, is fueling complexity in the life sciences industry. While the majority of companies have implemented a quality management system, these solutions often reside ¨C and are only accessible ¨C within a company¡¯s four walls1. This limits visibility and access throughout the entire global supply chain for critical stakeholders, especially external contract manufacturers and partners.
³Ô¹Ï±¬ÁÏ solves this with a suite of cloud applications ¨C Vault QMS and Vault QualityDocs ¨C that brings together quality processes and documentation throughout the enterprise. The new Vault QMS application incorporates external stakeholders into the full spectrum of quality processes, including deviations, lab investigations, complaints, internal and external audits, corrective and preventive actions, and change control. This reduces compliance risks and eliminates bottlenecks in bringing drugs and treatments to market.
¡°Quality management is more complicated today, involves more people and geographies, and requires greater transparency for regulatory authorities,¡± said Michael Jovanis, vice president of ³Ô¹Ï±¬ÁÏ Vault Quality. ¡°Customers struggle to keep quality processes and documentation in sync and incorporate external partners with disparate systems. Vault QMS meets the realities of today¡¯s quality manufacturing environment and connects the entire end-to-end quality process.¡±
³Ô¹Ï±¬ÁÏ Vault QMS is the latest application built on ³Ô¹Ï±¬ÁÏ Vault, a cloud platform and suite of applications that provide a single source of truth across the enterprise. Native interoperability between Vault applications empowers life sciences companies to streamline their business processes across an increasingly broad ecosystem of internal and external stakeholders.
³Ô¹Ï±¬ÁÏ Vault QMS will be available in late June 2016. To learn more about how cloud¨Cbased quality solutions are modernizing quality management, for the upcoming webinar, ¡°Modernizing Quality Management,¡± and see a live demonstration of Vault QMS on July 14, 2016.
Additional Information
For more on ³Ô¹Ï±¬ÁÏ Vault QMS, visit: veeva.com/QMS
For more on the ³Ô¹Ï±¬ÁÏ suite of quality products, visit: veeva.com/quality
Stay updated on the latest ³Ô¹Ï±¬ÁÏ news on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ has more than 400 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit .
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-K for the period ended January 31, 2016. This is available on the company¡¯s website at under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.
###
Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com